Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * O'Connor Padraig Andrew 2. Date of Event Requiring Statement (Month/Day/Year) 12/01/2025 3. Issuer Name and Ticker or Trading Symbol BOSTON SCIENTIFIC CORP [BSX] (Last) (First) (Middle) 300 BOSTON SCIENTIFIC WAY 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, Global Operations 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) MARLBOROUGH, MA 01752-1234 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 3,885 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/12/2028(1)	Common Stock	3,174(2)	(3)	D
Restricted Stock Units	(4)	02/13/2029(4)	Common Stock	2,002	(3)	D
Restricted Stock Units	(5)	02/14/2027(5)	Common Stock	2,380(6)	(3)	D
Restricted Stock Units	(7)	02/16/2026(7)	Common Stock	905(8)	(3)	D
Restricted Stock Units	(9)	05/02/2026(9)	Common Stock	1,802(10)	(3)	D
Restricted Stock Units	(11)	09/02/2029(11)	Common Stock	4,687	(3)	D
Stock Option (Right to Buy)	(12)	02/17/2031	Common Stock	13,822	$37.5	D
Stock Option (Right to Buy)	(13)	02/16/2032	Common Stock	12,050	$44.19	D
Stock Option (Right to Buy)	(14)	02/14/2033	Common Stock	14,290	$47.28	D
Stock Option (Right to Buy)	(15)	02/12/2034	Common Stock	12,998	$64.99	D
Stock Option (Right to Buy)	(16)	02/13/2035	Common Stock	5,151	$106.14	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
O'Connor Padraig Andrew 300 BOSTON SCIENTIFIC WAY MARLBOROUGH, MA 01752-1234			EVP, Global Operations

Signatures

/s/ Susan Thompson, Attorney-in-Fact		12/08/2025
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
(2)	This amount represents the unvested portion of RSUs awarded on February 12, 2024, which will continue to vest in three remaining installments on the anniversary of the date of grant.
(3)	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
(4)	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
(5)	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
(6)	This amount represents the unvested portion of RSUs awarded on February 14, 2023, which will continue to vest in two remaining installments on the anniversary of the date of grant.
(7)	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
(8)	This amount represents the unvested portion of RSUs awarded on February 16, 2022, which will continue to vest in one remaining installment on the anniversary of the date of grant.
(9)	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.
(10)	This amount represents the unvested portion of RSUs awarded on May 2, 2022, which will continue to vest in one remaining installment on the anniversary of the date of grant.
(11)	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant.
(12)	Grant to the reporting person of an option to purchase 13,822 shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
(13)	Grant to the reporting person of an option to purchase 12,050 shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
(14)	Grant to the reporting person of an option to purchase 14,290 shares of common stock vesting in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
(15)	Grant to the reporting person of an option to purchase 12,998 shares of common stock vesting in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
(16)	Grant to the reporting person of an option to purchase 5,151 shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
Remarks: oconnorpoa.txt

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.